# Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301

> **NCT00149929** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 246 (actual)

## Conditions studied

- Renal Transplant

## Interventions

- **DRUG:** Mycophenolate sodium (enteric coated)

## Key facts

- **NCT ID:** NCT00149929
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12
- **Primary completion:** 2003-04
- **Final completion:** 2003-04
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2011-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00149929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00149929, "Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00149929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*